Thrombosis and Haemostasis, Inhaltsverzeichnis Thromb Haemost 1989; 61(03): 532-534DOI: 10.1055/s-0038-1646630 International Committee Communications Schattauer GmbH Stuttgart Revision of the Protocol Recommended for Studies of Safety from Hepatitis of Clotting Factor Concentrates Authors Institutsangaben Pier Mannuccio Mannucci On behalf of the factor VIII and IX Subcommittee, Scientific and Standardization Committee of the International Society for Thrombosis and Hemostasis Massimo Colombo On behalf of the factor VIII and IX Subcommittee, Scientific and Standardization Committee of the International Society for Thrombosis and Hemostasis Artikel empfehlen Abstract als PDF herunterladen(opens in new window) Artikel einzeln kaufen(opens in new window) PDF (132 kb) Referenzen References 1 Schimpf K, Mannucci PM, Kreutz W, Brackmann HH, Auerswald G, Ciavarella N, Mosseler J, De Rosa V, Kraus B, Brueckmann CH, Mancuso G, Mittler U, Haschke F, Morfini M. Absence of hepatitis after treatment with a pasteurized factor VIII concentrate in patients with hemophilia and no previous transfusion. N Engl J Med 1987; 316: 918-922 2 Fletcher ML, Trowell JM, Craske J, Pavier K, Rizza CR. Non-A, non-B hepatitis after transfusion of factor VIII in infrequently treated patients. Br Med J 1983; 287: 1754-1757 3 Kemoff PB A, Lee CA, Karayiannis P, Thomas HC. High risk of non-A non-B hepatitis after a first exposure to volunteer or commercial clotting factor concentrates: effects of prophylactic immune serum globulin. Br J Haematol 1985; 60: 469-479 4 Fletcher M, Smith JK, Rizza CR. Absence of non-A, non-B hepatitis in patients receiving transfusion of severely heat-treated factor VIII concentrate. Ric Clin Lab 1986; 16 (01) 243 5 Collins JD, Bassendine MF, Codd AA, Collins A, Femer RE, James OF W. Prospective study of post-transfusion hepatitis after cardiac surgery in a British Centre. Br Med J 1983; 287: 1422-1424 6 Aach RD, Lander JJ, Scherman LA, Miller WV, Kahn RA, Gitnick GL, Hollinger FB, Werch J, Szmuness W, Stevens CE, Kellner A, Weiner JM, Mosley JW. Transfusion transmitted vimses: interim analysis of hepatitis among transfused and non-transfused patients. In: Viral Hepatitis. Vyias GN, Cohen SN, Schmid R. (eds) Franklin Institute Press; Philadelphia: 1978. pp 383-396 7 Alter H, Purcell RH, Feinstone SM, Holland PV, Morrow AG. Non-A, non-B hepatitis: a review and interim report of an ongoing prospective study. In: Viral Hepatitis. Vyias GN, Cohen SN, Schmid R. (eds) Franklin Institute Press; Philadelphia: 1978. pp 359-369 8 Seeff LB, Wright EC, Zimmerman HJ, Hoofnagle JH, Dietz AA, Felsher BF, Garcia-Pout PH, Gerety RJ, Greenlee HB, Kieman T, Leevy CM, Nath N, Schiff ER, Schwartz C, Tabor E, Tamburro C, Vlaticevic Z, Zemel R, Zimmon DS. Post-transfusion hepatitis 1973-1975. A Veterans Administration Cooperative Study In: Viral Hepatitis. Vyias GN, Cohen SN, Schmid R. (eds) Franklin Institute Press; Philadelphia: 1978. pp 383-396 9 Colombo M, Mannucci PM, Camelli V, Savidge GF, Gazengel C, Schinipf K. Non-A, non-B hepatitis transmitted by heat-treated factor VIII concentrates. Lancet 1985; 2: 1-6 10 Preston FE, Hay CR M, Dewar MS, Greaves M, Triger DR. NonA, non-B hepatitis and heat treated factor VIII concentrates. Lancet 1985; 2: 213 11 Mannucci PM, Colombo M, Rodeghiero F. Non-A, non-B hepatitis after factor VIII concentrate treated by heating and chloroform. Lancet 1985; 2: 1013 12 Kemoff PB A, Miller EJ, Savidge GF, Machin SJ, Dewar MS, Preston FE. Reduced risk of non-A, non-B hepatitis after first exposure to “wet heated” factor VIII concentrate. Br J Haematol 1987; 67: 207-211 13 Camelli V, Gomperts ED, Friedman A, Aledort LM, Hilgartner M, Dietrich S, Fedor EJ. Assessment for evidence of non-A, non-B hepatitis in patients given n-heptane suspended heat-treated clotting factor concentrates. Thromb Res 1987; 46: 827-834 14 Hanley JA, Lippman-Hand A. If nothing goes wrong, is everything all right. JAMA 1983; 249: 1743-1745 15 Sugg U, Erhardt S, Morgenroth T, Flehmig B. Is the use of the term “Posttransfusion hepatitis type B” in its conventional sense still justifiable. Vox Sang 1983; 44: 305-311 16 Koziol DE, Holland PV, Ailing DW, Melpolder JC, Solomon RE, Purcell RH, Hudson LM, Shoup FJ, Krakauer H, Alter HJ. Antibody to hepatitis B core antigen as a paradoxical marker for non-A, non-B hepatitis agents in donated blood. Ann Intern Med 1986; 104: 488-495 17 Colombo M, Zanuso F, Rebulla P, Giovanetti AM, Sirchia G. Increasing the use of predeposited autologous blood for transfusion. N Engl J Med 1978; 317: 570
